Inhibition of intraocular fibrin formation after infusion of low-molecular-weight heparin during combined phacoemulsification–trabeculectomy surgery

References 

1. Mamalis N, Lohner S, Rand AN, Crandall AS. Combined phacoemulsification, intraocular lens implantation, and trabeculectomy. J Cataract Refract Surg. 1996;22:467–473
   • MEDLINE
2. Wedrich A, Menapace R, Radax U, Papapanos P. Long-term results of combined trabeculectomy and small incision cataract surgery. J Cataract Refract Surg. 1995;21:49–54
   • MEDLINE
3. Nasir MA, Toth CA, Mittra RA. Recombinant hirudin for prevention of experimental postoperative intraocular fibrin. Am J Ophthalmol. 1996;121:554–560
   • MEDLINE
4. Iverson DA, Katsura H, Hartzer MK, Blumenkranz MS. Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy. Arch Ophthalmol. 1991;109:405–409
   • MEDLINE
5. Heiligenhaus A, Steinmetz B, Lapuente R, et al. Recombinant tissue plasminogen in cases with fibrin formation after cataract surgery: a prospective randomised multicenter study. Br J Ophthalmol. 1998;82:810–815
   • MEDLINE
   • CrossRef
6. Wedrich A, Menapace R, Ries E, Polzer I. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery. J Cataract Refractive Surg. 1997;23:873–877
7. Siatiri H, Beheshtnezhad AH, Asghari H, et al. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery. Br J Ophthalmol. 2005;89:1458–1461
   • MEDLINE
   • CrossRef
8. Rumelt S, Stolovich C, Segal ZI, Rehany U. Intraoperative enoxaparin minimizes inflammatory reaction after pediatric cataract surgery. Am J Ophthalmol. 2006;141:433–437
   • Abstract
   • Full Text
   • Full-Text PDF (91 KB)
   • CrossRef
9. Rowland FN, Donovan MJ, Gillies C, et al. Fibrin: mediator of in vivo and in vitro injury and inflammation. Curr Eye Res. 1985;4:537–553
   • MEDLINE
   • CrossRef
10. Vidaurri-Leal JS, Glaser BM. Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol. 1984;102:1376–1379
    • MEDLINE
11. Kondo H, Hayashi H, Oshima K. [Low molecular weight heparin inhibits raised intraocular pressure following intracameral administration of sodium hyaluronate]. [Japanese] Nippon Ganka Gakkai Zasshi. 1994;98:423–428
    • MEDLINE
12. Abdollahi A, Naini M-T, Shams H, Zarei R. Effect of low-molecular-weight heparin on postoperative inflammation in phacomorphic glaucoma. Arch Iranian Med. 2002;5:225–229
13. Johnson RN, Balyeat E, Stern WH. Heparin prophylaxis for intraocular fibrin. Ophthalmology. 1987;94:597–601
    • Abstract
14. Trope GE, Pavlin CJ, Bau A, et al. Malignant glaucoma; clinical and ultrasound biomicroscopic features. Ophthalmology. 1994;101:1030–1035
    • Abstract
15. Taguri AH, Devlin H. Capsular phimosis following phacotrabeculectomy. Ophthalmic Surg Lasers Imaging. 2005;36:245–248
    • MEDLINE
16. Dabbs CK, Aaberg TM, Aguilar HE, et al. Complications of tissue plasminogen activator therapy after vitrectomy for diabetes. Am J Ophthalmol. 1990;110:354–360
    • MEDLINE
17. Jaffe GJ, Abrams GW, Williams GA, Han DP. Tissue plasminogen activator for postvitrectomy fibrin formation. Ophthalmology. 1990;97:184–189
    • Abstract
18. Williams DF, Bennett SR, Abrams GW, et al. Low-dose intraocular tissue plasminogen activator for treatment of postvitrectomy fibrin formation. [letter] Am J Ophthalmol. 1990;109:606–607
    • MEDLINE
19. Lundy DC, Sidoti P, Winarko T, et al. Intracameral tissue plasminogen activator after glaucoma surgery; indications, effectiveness, and complications. Ophthalmology. 1996;103:274–282
    • Abstract
20. Althaus C, Schelle C, Sundmacher R. Akute bandförmige Keratopathie nach intraokularer Fibrinolyse mit rekombinantem Tissue-Plasminogen-Aktivator (rt-PA). Klin Monatsbl Augenheilkd. 1996;209:43–46